RE: RE: RE: RE: SOON A conference call would have been a good idea.
-They could have given investors and analysts some colour on April and May scans.
- Discuss the MYRAK acquisition. We are taking a substantial dilution and I would like to know if its worth it.
Does anyone know if MYTRAK's revenue?